Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spruce Biosciences Inc
(NQ:
SPRB
)
0.5525
+0.0084 (+1.54%)
Streaming Delayed Price
Updated: 12:53 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Spruce Biosciences Inc
< Previous
1
2
3
4
5
6
7
Next >
Analyst Expectations for Spruce Biosciences's Future
May 16, 2023
Via
Benzinga
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 15, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
May 04, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
4 Analysts Have This to Say About Spruce Biosciences
March 23, 2023
Via
Benzinga
Spruce Biosciences Shares Skyrocket After Licensing Pact For Lead Program
January 06, 2023
Via
Benzinga
Spruce Biosciences to Participate in May Investor Conferences
May 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
March 23, 2023
Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose...
Via
Benzinga
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
March 16, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 28, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
February 22, 2023
The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 09, 2023
Via
Benzinga
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference
February 01, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Peering Into Spruce Biosciences's Recent Short Interest
January 09, 2023
Spruce Biosciences's (NASDAQ:SPRB) short percent of float has risen 17.3% since its last report. The company recently reported that it has 588 thousand shares sold short, which is 3.39% of all regular...
Via
Benzinga
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
January 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 06, 2023
Via
Benzinga
Dow Jumps 700 Points; S&P 500 Rises Over 2%
January 06, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.
Via
Benzinga
Spruce Biosciences (NASDAQ: SPRB) Enters Into Collaboration with Kaken Pharmaceutical to Develop Tildacerfont for CAH in Japan
January 06, 2023
Spruce Biosciences, Inc. (NASDAQ: SPRB) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development and
Via
Spotlight Growth
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via
Benzinga
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
January 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
Via
Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 06, 2023
The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via
Benzinga
Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan
January 05, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 21, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday
Via
InvestorPlace
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
December 21, 2022
Gainers ADC Therapeutics SA (NASDAQ: ADCT) shares rose 36.8% to $4.35 in pre-market trading. ADC Therapeutics and Sobi announced European Commission approval of ZYNLONTA for the treatment of relapsed...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.